Trump's Drug Pricing News Boosts Biotechs

Trump's Drug Pricing News Boosts Biotechs


Shares of biotech stocks were on fire this week, due largely to news that President Trump and his advisers are working on an executive order meant to restrain escalating drug prices. Trump's plan is good news for drug developers because its appears there won't be new restrictions on drug companies nor will Medicare be allowed to use its market muscle to keep drug prices low.



from Biotech News